Sam Cage

Articles

November 25, 03:29pm EST
UPDATE 3-Novartis strikes licensing deal with Incyte 

* Gains access to 2 therapies for blood disorders, cancers  Full Article 

November 19, 07:56pm EST Photo
Deaths not linked to H1N1 vaccine: WHO 

GENEVA (Reuters) - The World Health Organization said on Thursday the H1N1 vaccine had been cleared of blame for 41 deaths which health authorities worldwide had investigated after suspicions they might have been caused by the inoculation.  Full Article 

November 19, 06:23pm EST
Deaths not linked to H1N1 vaccine - WHO 

* About 40 deaths reported, no link to vaccine established * Fewer than dozen cases of Guillain-Barre syndrome (Adds China deaths in new paras 8-9; global death toll, 15) By Stephanie Nebehay GENEVA, Nov 19 (Reuters) - The World Health Organisation said ...  Full Article 

November 19, 06:23pm EST
UPDATE 2-Deaths not linked to H1N1 vaccine - WHO 

* About 40 deaths reported, no link to vaccine established  Full Article 

November 19, 06:23pm EST
Deaths not linked to H1N1 vaccine - WHO 

* About 40 deaths reported, no link to vaccine established * Fewer than dozen cases of Guillain-Barre syndrome (Adds China deaths in new paras 8-9; global death toll, 15) By Stephanie Nebehay GENEVA, Nov 19 (Reuters) - The World Health Organisation said ...  Full Article 

November 19, 07:56pm EST Photo
Deaths not linked to H1N1 vaccine: WHO 

GENEVA (Reuters) - The World Health Organization said on Thursday the H1N1 vaccine had been cleared of blame for 41 deaths which health authorities worldwide had investigated after suspicions they might have been caused by the inoculation.  Full Article 

November 18, 08:41am EST
Biotech Cosmo aims to buy rival BioXell for $41 mln 

* BioXell shares rise 15 pct, top gainers in Switzerland  Full Article 

November 16, 08:42am EST
UPDATE 2-Addex set for partner deal after drug hits target 

* May set up partner deal on potential billion dollar seller  Full Article 

November 16, 06:01am EST
Addex lead drug hits target in mid-stage study 

* Expects results from second phase IIb trial in gerd in Jan  Full Article 

November 15, 09:44am EST
UBS made no request to buy back toxic assets-press 

ZURICH, Nov 15 (Reuters) - Switzerland's financial regulator FINMA has received no request from UBS AG <UBSN.VX> to buy back toxic assets transferred to the Swiss central bank last year, FINMA's head was quoted on Sunday as saying.  Full Article